Voleon Capital Management’s Vaxcyte PCVX Stock Holding History

Voleon Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,337	Closed	-$310K	–	886
2026 Q1	$310K	Sell	5,337 -26,442	-83%	-$1.44M	0.01%	665
2025 Q4	$1.47M	Sell	31,779 -47,148	-60%	-$2.11M	0.03%	382
2025 Q3	$2.84M	Buy	+78,927	New	+$2.61M	0.07%	269

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Voleon Capital Management's PCVX Position: Q2 2026 in Review

Voleon Capital Management sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 5,337 shares — an estimated $310K sold.

Voleon Capital Management first reported a position in PCVX in Q3 2025 and held it in 3 quarters. The position peaked at $2.84M in Q3 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Voleon Capital Management reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
Voleon Capital Management sold 5,337 Vaxcyte shares in Q2 2026, an estimated $310K.
Voleon Capital Management first reported a position in Vaxcyte in Q3 2025 and held it in 3 quarters.
Voleon Capital Management's Vaxcyte position peaked at $2.84M in Q3 2025.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.